Trends for 2026: Targeted AI, continuous trials, and navigating uncertainty
In 2026, clinical trial teams must be prepared to navigate market uncertainty and identify high-impact areas for AI adoption to remain competitive. We spoke with Jennifer Duff, Executive Vice President and General Manager of Zelta, to understand her view on the key industry trends that will define the year ahead.
